Effect of long term vitamin d supplementation on biomarkers of inflammation in latino and african-american subjects with pre-diabetes and hypovitaminosis d

Hormone and Metabolic Research

Volumn 47, Issue 4, 2015, Pages 280-283

  Sinha Hikim, I ^a,b   Duran, P ^a   Shen, R ^a   Lee, M ^a,b   Friedman, T C ^a,b   Davidson, M B ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hypovitaminosis D; inflammation; pre diabetes; vitamin D supplementation

Indexed keywords

25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN C; VITAMIN D;

ADULT; AFRICAN AMERICAN; ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; VITAMIN D DEFICIENCY;

ADULT; AFRICAN AMERICANS; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; FEMALE; HISPANIC AMERICANS; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MALE; MIDDLE AGED; PLACEBOS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDIABETIC STATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84939883118     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1383652     Document Type: Article

References (29)

1. Gupta A. K., Brashear M. M., Johnson W. D. Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care: 2011; 34 658 660
2. Pinelli N. R., Jaber L. A., Brown M. B., Herman W. H. Serum 25-hydroxyvitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care: 2010; 33 1373 1375
3. Shankar A., Sabanayagam C., Kalidindi S. Serum 25-hydroxyvitamin D levels and prediabetes among subjects free of diabetes. Diabetes Care: 2011; 34 1114 1119
4. Hyppönen E., Boucher B. J., Berry D. J., Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes: 2008; 57 298 305
5. Lu L., Yu Z., Pan A., Hu F. B., Franco O. H., Li H., Li X., Yang X., Chen Y., Lin X. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care: 2009; 32 1278 1283
6. Kayaniyil S., Vieth R., Harris S. B., Retnakaran R., Knight J. A., Gerstein H. C., Perkins B. A., Zinman B., Hanley A. Association of 25 (OH) D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab: 2011; 96 168 175
7. Thorand B., Zierer A., Huth C., Linseisen J., Meisinger C., Roden M., Peters A., Koenig W., Herder C. Effect of serum 25-hydroxyviamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsuburg study. Diabetes Care: 2011; 34 2320 2322
8. Shoelson S. E., Goldfine A. B. Inflammation and insulin resistance. J Clin Invest: 2006; 116 1793 1801
9. Holick M. S. Vitamin D deficiency. N Engl J Med: 2007; 357 266 281
10. Chandler P. D., Scott J. B., Drake B. F., Ng K., Manson J. E., Rifai N., Chan A. T., Bennett C. G., Hollis B. W., Giovannucci E. L., Emmons K. M., Fuchs C. S. Impact of vitamin D supplementation on inflammatory markers in African-Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer Prev Res (Phila): 2014; 7 218 225
11. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Eng D., Boehm B. O., Weihrauch G., Maerz W. Independent association of lowe serum 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med: 2008; 168 1340 1349
12. Laird E., McNulty H., Ward M., Hoey L., McSorley E., Wallace JM W., Carson E., Molloy A. M., Healy M., Casey M. C., Cunningham C., Strain J. J. Vitamin D deficiency is associated with inflammation in older adults. J Clin Endocrinol Metab: 2014; 99 1807 1815
13. Willis K. S., Smith D. T., Broughton K. S., Larson-Meyer D. E. Vitamin D status and biomarkers of inflammation in runners. Open Access J Sports Med: 2012; 3 35 42
14. Barker T., Martins T. B., Hill H. R. Kjeidsberg Dixon B. M., Schneider E. D., Henriksen V. T., Weaver L. K. Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur J Appl Physiol: 2013; 113 1523 1534
15. Sun X., Cao Z-B, Zhang Y., Ishimi Y., Tabata I., Higuchi M. Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients: 2014; 6 221 230
16. Barker T., Henriksen V. T., Rogers V. E., Aguirre D., Trawick R. H., Rasmussen G. L., Momberger N. G. Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis. Redox Biol: 2014; 2 466 474
17. Fabri M., Stenger S., Shin D-M, Yuk J-M, Liu P. T., Realegeno S., Lee H-M, Krutzik S. R., Schenk M., Sieling P. A., Teles R., Montoya D., Iyer S. S., Bruns H., Lewinsohn D. M., Hollis B. W., Hewison M., Adams J. S., Steinmeyer A., Zugel U., Cheng G., Jo E-K, Bloom B. R., Modlin R. L. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci Transl Med: 2011; 3 104ra102
18. Hewison M. Update on vitamin D and human immunity. Clin Endocrinol: 2012; 76 315 323
19. Wu-Wong J. R., Nakane M., Ma J. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells. J Vasc Res: 2007; 44 11 18
20. Arnson Y., Itzhaky D., Mosseri M., Barak V., Tzur B., Agmon-Levin N., Amital H. Vitamin D inflammatory cytokines and coronary events: a comprehensive review. Clin Rev Allergy Immunol: 2013; 45 236 247
21. Davidson M. B., Duran P., Lee M. L., Friedman T. C. High dose vitamin D supplementation in people with pre-diabetes and hypovitaminosis D. Diabetes Care: 2013; 36 260 266
22. Pittas A. G., Harris S. S., Stark P. C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care: 2007; 30 980 986
23. Belenchia A. M., Tosh A. K., Hillman L. S., Peterson C. A. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr: 2013; 97 774 781
24. Neyestani T. R., Nikooyeh B., Alavi-Majd H., Shariatzadeh N., Kalayi A. Tayebinejad Heravufard S., Salekzamani S., Zahedirad M. Improvement of vitamin D status via daily iintake of fortified yogurt drink with or without extra calcium ameliorates systemic inflammatory biomarkers, include adipokine, in the subjects with type 2 diabetes. J Clin Endocrinol Metab: 2012; 97 2005 2011
25. Kamycheva E., Berg V., Jorde R. Insulin-like growth factor 1, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects. Endocrine: 2013; 43 412 418
26. Woodworth S., Woodworth Z. Vitamin D elevates growth factor. Endocrine Soc: 2009; 41 47
27. Ross A. C., Manson J. E., Abrams S. A., Aloia J. F., Brannon P. M., Clinton S. K., Ramon A., Durazo-Arvizu J., Gallagher Christopher, Gallo R. L., Jones G., Kovacs C. S., Mayne S. T., Rosen C. F., Shapses S. A. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. J Clin Endocrinol Metab: 2011; 96 53 58
28. Bollan M. J., Grey A., Gamble G. D., Reid I. A. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes-Endocrinol: 2014; 2 307 320
29. Pittas A. G., Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol: 2010; 121 425 429